EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.

RELEVANT LEGISLATION
Last updated 26 srpnja 2024. Database contains 4821 unique substances/entries.
Filter the list

Stranica 32 od 97
50 Broj stavki po stranici
Prikazano 1.551 - 1.600 od 4.821 rezultata.
Substance Name
EC No.
CAS No.
EU CLP (1272/2008)
EU_BA Directive 2000/54/EC
EU REACH: List of SVHC
Naphtha (coal), solvent extn., hydrocracked [Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 °C to 180 °C (86°F to 356°F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]
Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30°C to 180°C (86°F to 356°F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.
302-690-1
94114-54-2
Carc. 1B; Muta. 1B
Naphtha (coal), distn. residues; Light Oil Redistillate, high boiling [The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.]
The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.
292-636-2
90641-12-6
Carc. 1B; Muta. 1B
naled (ISO); 1,2-dibromo-2,2-dichloroethyl dimethyl phosphate
206-098-3
300-76-5
Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2
Naegleria fowleri
-
-
P Parasites
nabam (ISO); disodium ethylenebis(N, N'-dithiocarbamate)
205-547-0
142-59-6
Acute Tox. 4; STOT SE 3; Skin Sens. 1
N5,N5-diethyltoluene-2,5-diamine monohydrochloride; 4-diethylamino-2-methylaniline monohydrochloride
218-130-3
2051-79-8
Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
N2,N4,N6-tris{4-[(1,4-dimethylpentyl)amino]phenyl}-1,3,5-triazine-2,4,6-triamine
426-150-0
121246-28-4
Skin Sens. 1
N-{2-[[1,1'-bi (cyclopropyl)]-2-yl] phenyl}-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide; sedaxane
688-331-2
874967-67-6
Carc. 2
n-pentyl-isopentylphthalate
-
-
Repr. 1B
N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine
431-060-1
153719-38-1
Acute Tox. 4; Skin Sens. 1
N-methylformamide
204-624-6
123-39-7
Repr. 1B; Acute Tox. 4
N-methylbenzene-1,2-diammonium hydrogen phosphate
424-460-0
283167-56-6
Acute Tox. 4; Skin Sens. 1
N-methylaniline
202-870-9
100-61-8
Acute Tox. 3; STOT RE 2
N-methylacetamide
201-182-6
79-16-3
Repr. 1B
yes
N-methyl-p-toluidine
210-769-6
623-08-5
Acute Tox. 3; STOT RE 2
N-methyl-o-toluidine
210-260-9
611-21-2
Acute Tox. 3; STOT RE 2
N-methyl-N-cyanomethylmorpholiniummethylsulfate
429-340-1
186295-11-4
Acute Tox. 4; Eye Dam. 1
N-methyl-N-2,4,6-tetranitroaniline; tetryl
207-531-9
479-45-8
Expl. 1.1; Acute Tox. 3; STOT RE 2
N-methyl-m-toluidine
211-795-0
696-44-6
Acute Tox. 3; STOT RE 2
N-methyl-4-(p-formylstyryl)pyridinium methylsulfate
N-METHYL-4-(P-FORMYLSTYRYL)-PYRIDINIUM METHYLSULFATE; SBQ; SBQ-SALZ
418-240-3
74401-04-0
Skin Sens. 1
N-methyl-2-pyrrolidone; 1-methyl-2-pyrrolidone
212-828-1
872-50-4
Repr. 1B; STOT SE 3; Skin Irrit. 2; Eye Irrit. 2
yes
N-methoxy-N-[1-methyl-2-(2,4,6-trichlorophenyl)-ethyl]-3-(difluoromethyl)- 1-methylpyrazole-4-carboxamide; pydiflumetofen
817-852-1
1228284-64-7
Carc. 2; Repr. 2
N-isopropyl-N'-phenyl-p-phenylenediamine
202-969-7
101-72-4
Acute Tox. 4; Skin Sens. 1
n-hexyllithium
N-HEXYLLITHIUM
404-950-0
21369-64-2
Water-react. 1; Pyr. Sol. 1; Skin Corr. 1A
n-hexane
203-777-6
110-54-3
Flam. Liq. 2; Repr. 2; Asp. Tox. 1; STOT RE 2; Skin Irrit. 2; STOT SE 3
N-hexadecyl(or octadecyl)-N-hexadecyl (or octadecyl)benzamide
DTBA
401-980-6
-
Skin Irrit. 2; Skin Sens. 1
N-ethylaniline
203-135-5
103-69-5
Acute Tox. 3; STOT RE 2
N-ethyl-N-methylpiperidinium iodide
CATALYST 4017
407-780-5
4186-71-4
Acute Tox. 4
N-ethyl-3-trimethoxysilyl-2-methyl-propanamine
437-720-3
227085-51-0
Eye Dam. 1
N-ethyl-2-pyrrolidone; 1-ethylpyrrolidin-2-one
220-250-6
2687-91-4
Repr. 1B
N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate
DIMETHYLPAPAMIDOLAURDIMONIUM TOSYLATE
421-130-8
156679-41-3
Eye Dam. 1; Skin Sens. 1
N-cyclohexylbenzothiazole-2- sulphenamide
202-411-2
95-33-0
Skin Sens. 1
N-cyclohexyl-S, S-dioxo; benzo[b]tiophene-2-carboxamide
PREVENTOL VP OC 3061
423-990-1
149118-66-1
Acute Tox. 4; Eye Dam. 1
N-carboxymethyliminobis(ethylenenitrilo)tetra (acetic acid)
200-652-8
67-43-6
Acute Tox. 4; STOT RE 2; Eye Irrit. 2
n-butyronitrile
203-700-6
109-74-0
Flam. Liq. 2; Acute Tox. 3
N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide
DISPERSOL YELLOW XF
407-970-8
75511-91-0
Skin Sens. 1
N-butyl-2-(4-morpholinylcarbonyl)benzamide
EP 389
407-730-2
104958-67-0
Eye Irrit. 2; Skin Sens. 1
n-butyl propionate
209-669-5
590-01-2
Flam. Liq. 3
n-butyl methacrylate
202-615-1
97-88-1
Flam. Liq. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1
n-butyl acrylate
205-480-7
141-32-2
Flam. Liq. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1
n-butyl acetate
204-658-1
123-86-4
Flam. Liq. 3; STOT SE 3
N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine
425-300-2
186450-73-7
Skin Sens. 1
N-amidino-N-methylglycine-2-oxopropionate
429-120-5
208535-04-0
Eye Dam. 1
N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide
424-550-1
84245-12-5
Carc. 1B; Muta. 1B; Repr. 1B
N-[4-cyano-3-trifluoromethylphenyl]methacrylamide
427-880-2
90357-53-2
STOT RE 2
N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide
BENZANILID-DISPERSE-INTERMEDIATE ZP 9955
411-590-8
70693-57-1
Skin Corr. 1B
N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide
423-530-8
152828-23-4
STOT RE 1; Acute Tox. 4
N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate
DS 100
415-060-7
1379678-87-1
Eye Dam. 1; Skin Sens. 1
N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide
DISPERSOL BLUE C-4G COLOUR; SUBSTANCE H87919
416-860-9
777891-21-1
Repr. 2; Skin Sens. 1
N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-N-carboxyanhydride
430-360-8
84793-24-8
Eye Dam. 1; Skin Sens. 1
Stranica 32 od 97
50 Broj stavki po stranici
Prikazano 1.551 - 1.600 od 4.821 rezultata.

Export search results to: